Tokyo Tape
Sign in
← J Frontier

Quarterly report · Q2

2934.TEDINET S100PYFW
Period2022-06-01 → 2022-11-30
Filed2023-01-13
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 48
MetricValuePeriodScopeSource row
Revenue¥9.1bn2022-06-01 → 2022-11-30Cons.Net sales
Revenue¥11.9bn2021-06-01 → 2022-05-31Cons.Net sales (5-year summary)
Revenue¥3.9bn2021-06-01 → 2021-11-30Cons.Net sales
Operating income−¥368m2022-06-01 → 2022-11-30Cons.Operating income
Operating income¥264m2021-06-01 → 2021-11-30Cons.Operating income
Ordinary income−¥382m2022-06-01 → 2022-11-30Cons.Ordinary income
Ordinary income¥713m2021-06-01 → 2022-05-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥238m2021-06-01 → 2021-11-30Cons.Ordinary income
Profit before tax−¥382m2022-06-01 → 2022-11-30Cons.Income before income taxes
Profit before tax¥238m2021-06-01 → 2021-11-30Cons.Income before income taxes
Net income (owners)−¥349m2022-06-01 → 2022-11-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥401m2021-06-01 → 2022-05-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥156m2021-06-01 → 2021-11-30Cons.Profit loss attributable to owners of parent
Net income−¥308m2022-06-01 → 2022-11-30Cons.Profit loss
Net income¥156m2021-06-01 → 2021-11-30Cons.Profit loss
Total assets¥7.8bnat 2022-11-30Cons.Assets
Total assets¥6.1bnat 2022-05-31Cons.Assets
Total assets¥5.5bnat 2021-11-30Cons.Total assets (5-year summary)
Total liabilities¥3.6bnat 2022-11-30Cons.Liabilities
Total liabilities¥1.9bnat 2022-05-31Cons.Liabilities
Net assets / equity¥4.2bnat 2022-11-30Cons.Net assets
Net assets / equity¥4.2bnat 2022-05-31Cons.Net assets
Net assets / equity¥4.3bnat 2021-11-30Cons.Net assets (5-year summary)
Cash and deposits¥2.9bnat 2022-11-30Cons.Cash and deposits
Cash and deposits¥3.0bnat 2022-05-31Cons.Cash and deposits
Cash & equivalents¥2.8bnat 2022-11-30Cons.Cash and cash equivalents
Cash & equivalents¥3.0bnat 2022-05-31Cons.Cash and cash equivalents
Cash & equivalents¥4.1bnat 2021-11-30Cons.Cash and cash equivalents
Cash & equivalents¥1.6bnat 2021-05-31dCons.Cash and cash equivalents
Operating cash flow−¥594m2022-06-01 → 2022-11-30Cons.Net cash provided by used in operating activities
Operating cash flow−¥367m2021-06-01 → 2022-05-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow−¥288m2021-06-01 → 2021-11-30Cons.Net cash provided by used in operating activities
Investing cash flow−¥800m2022-06-01 → 2022-11-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥860m2021-06-01 → 2022-05-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥77m2021-06-01 → 2021-11-30Cons.Net cash provided by used in investment activities
Financing cash flow¥1.3bn2022-06-01 → 2022-11-30Cons.Net cash provided by used in financing activities
Financing cash flow¥2.6bn2021-06-01 → 2022-05-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow¥2.8bn2021-06-01 → 2021-11-30Cons.Net cash provided by used in financing activities
EPS (basic)¥-76.452022-06-01 → 2022-11-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-47.822022-09-01 → 2022-11-30dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥90.642021-06-01 → 2022-05-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥36.312021-06-01 → 2021-11-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥19.012021-09-01 → 2021-11-30dCons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥86.682021-06-01 → 2022-05-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥34.332021-06-01 → 2021-11-30Cons.Diluted earnings per share (5-year summary)
Equity ratio50.9%at 2022-11-30Cons.Equity to asset ratio (5-year summary)
Equity ratio68.2%at 2022-05-31Cons.Equity to asset ratio (5-year summary)
Equity ratio78.9%at 2021-11-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 31
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2022-06-01 → 2022-11-30−¥84m
Reconciling Itemsreconcilingrevenue intersegment2022-06-01 → 2022-11-30−¥84m
Reconciling Itemsreconcilingsegment profit2022-06-01 → 2022-11-30−¥277m
jpcrp040300-q2r_E33800-000Healthcare Marketing Businessreportable segmentrevenue2022-06-01 → 2022-11-30¥3.0bn
jpcrp040300-q2r_E33800-000Healthcare Marketing Businessreportable segmentrevenue external2022-06-01 → 2022-11-30¥2.9bn
jpcrp040300-q2r_E33800-000Healthcare Marketing Businessreportable segmentrevenue intersegment2022-06-01 → 2022-11-30¥84m
jpcrp040300-q2r_E33800-000Healthcare Marketing Businessreportable segmentsegment profit2022-06-01 → 2022-11-30¥55m
jpcrp040300-q2r_E33800-000Healthcare Sales Businessreportable segmentrevenue2022-06-01 → 2022-11-30¥2.0bn
jpcrp040300-q2r_E33800-000Healthcare Sales Businessreportable segmentrevenue external2022-06-01 → 2022-11-30¥2.0bn
jpcrp040300-q2r_E33800-000Healthcare Sales Businessreportable segmentsegment profit2022-06-01 → 2022-11-30¥266m
jpcrp040300-q2r_E33800-000Medical Care Sales Businessreportable segmentrevenue2022-06-01 → 2022-11-30¥4.2bn
jpcrp040300-q2r_E33800-000Medical Care Sales Businessreportable segmentrevenue external2022-06-01 → 2022-11-30¥4.2bn
jpcrp040300-q2r_E33800-000Medical Care Sales Businessreportable segmentrevenue intersegment2022-06-01 → 2022-11-30¥181,000
jpcrp040300-q2r_E33800-000Medical Care Sales Businessreportable segmentsegment profit2022-06-01 → 2022-11-30−¥412m
Total Of Reportable Segments And Otherssegment totalrevenue2022-06-01 → 2022-11-30¥9.2bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-06-01 → 2022-11-30¥9.1bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-06-01 → 2022-11-30¥84m
Total Of Reportable Segments And Otherssegment totalsegment profit2022-06-01 → 2022-11-30−¥91m
Reconciling Itemsreconcilingsegment profit2021-06-01 → 2021-11-30−¥195m
jpcrp040300-q2r_E33800-000Healthcare Marketing Businessreportable segmentrevenue2021-06-01 → 2021-11-30¥552m
jpcrp040300-q2r_E33800-000Healthcare Marketing Businessreportable segmentrevenue external2021-06-01 → 2021-11-30¥552m
jpcrp040300-q2r_E33800-000Healthcare Marketing Businessreportable segmentsegment profit2021-06-01 → 2021-11-30¥64m
jpcrp040300-q2r_E33800-000Healthcare Sales Businessreportable segmentrevenue2021-06-01 → 2021-11-30¥1.9bn
jpcrp040300-q2r_E33800-000Healthcare Sales Businessreportable segmentrevenue external2021-06-01 → 2021-11-30¥1.9bn
jpcrp040300-q2r_E33800-000Healthcare Sales Businessreportable segmentsegment profit2021-06-01 → 2021-11-30¥391m
jpcrp040300-q2r_E33800-000Medical Care Sales Businessreportable segmentrevenue2021-06-01 → 2021-11-30¥1.4bn
jpcrp040300-q2r_E33800-000Medical Care Sales Businessreportable segmentrevenue external2021-06-01 → 2021-11-30¥1.4bn
jpcrp040300-q2r_E33800-000Medical Care Sales Businessreportable segmentsegment profit2021-06-01 → 2021-11-30¥5m
Total Of Reportable Segments And Otherssegment totalrevenue2021-06-01 → 2021-11-30¥3.9bn
Total Of Reportable Segments And Otherssegment totalrevenue external2021-06-01 → 2021-11-30¥3.9bn
Total Of Reportable Segments And Otherssegment totalsegment profit2021-06-01 → 2021-11-30¥459m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 489
ItemContextValueUnit
Net increase decrease in short term loans payable fin cfPrior1YTDDuration－JPY
Net increase decrease in short term loans payable fin cfCurrentYTDDuration147498000JPY
Proceeds from long term loans payable fin cfPrior1YTDDuration－JPY
Proceeds from long term loans payable fin cfCurrentYTDDuration1100000000JPY
Repayment of long term loans payable fin cfPrior1YTDDuration-45844000JPY
Repayment of long term loans payable fin cfCurrentYTDDuration-126175000JPY
Redemption of bonds fin cfPrior1YTDDuration－JPY
Redemption of bonds fin cfCurrentYTDDuration-33000000JPY
Proceeds from issuance of common stock fin cfPrior1YTDDuration2865321000JPY
Proceeds from issuance of common stock fin cfCurrentYTDDuration－JPY
Proceeds from issuance of stock resulting from exercise of subscription rights to shares fin cfPrior1YTDDuration19050000JPY
Proceeds from issuance of stock resulting from exercise of subscription rights to shares fin cfCurrentYTDDuration175181000JPY
Other net fin cfPrior1YTDDuration－JPY
Other net fin cfCurrentYTDDuration2505000JPY
Net cash provided by used in financing activitiesPrior1YTDDuration2838527000JPY
Net cash provided by used in financing activitiesCurrentYTDDuration1266010000JPY
Net increase decrease in cash and cash equivalentsPrior1YTDDuration2473256000JPY
Net increase decrease in cash and cash equivalentsCurrentYTDDuration-128072000JPY
Cash and cash equivalentsPrior2YearInstant1631094000JPY
Cash and cash equivalentsPrior1YearInstant2968654000JPY
Cash and cash equivalentsPrior1QuarterInstant4104351000JPY
Cash and cash equivalentsCurrentQuarterInstant2840582000JPY
Ec advertising expenses sgaPrior1YTDDuration1631806000JPY
Ec advertising expenses sgaCurrentYTDDuration1864484000JPY
Depreciation sgaPrior1YTDDuration2882000JPY
Depreciation sgaCurrentYTDDuration7774000JPY
Amortization of goodwill sgaPrior1YTDDuration2727000JPY
Amortization of goodwill sgaCurrentYTDDuration86184000JPY
Provision for bonuses selling expensesPrior1YTDDuration8112000JPY
Provision for bonuses selling expensesCurrentYTDDuration29813000JPY
Provision for point card certificatesCurrentYTDDuration10532000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q2r_E33800-000MedicalCareSalesBusinessReportableSegmentMember1445463000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q2r_E33800-000HealthcareSalesBusinessReportableSegmentMember1915186000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q2r_E33800-000HealthcareMarketingBusinessReportableSegmentMember552036000JPY
Revenues from external customersPrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember3912686000JPY
Revenues from external customersPrior1YTDDuration_ReconcilingItemsMember－JPY
Revenues from external customersPrior1YTDDuration3912686000JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q2r_E33800-000MedicalCareSalesBusinessReportableSegmentMember－JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q2r_E33800-000HealthcareSalesBusinessReportableSegmentMember－JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q2r_E33800-000HealthcareMarketingBusinessReportableSegmentMember－JPY
Transactions with other segmentsPrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember－JPY
Transactions with other segmentsPrior1YTDDuration_ReconcilingItemsMember－JPY
Transactions with other segmentsPrior1YTDDuration－JPY
Net salesPrior1YTDDuration_jpcrp040300-q2r_E33800-000MedicalCareSalesBusinessReportableSegmentMember1445463000JPY
Net salesPrior1YTDDuration_jpcrp040300-q2r_E33800-000HealthcareSalesBusinessReportableSegmentMember1915186000JPY
Net salesPrior1YTDDuration_jpcrp040300-q2r_E33800-000HealthcareMarketingBusinessReportableSegmentMember552036000JPY
Net salesPrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember3912686000JPY
Net salesPrior1YTDDuration_ReconcilingItemsMember－JPY
Net salesPrior1YTDDuration3912686000JPY
Operating incomePrior1YTDDuration_jpcrp040300-q2r_E33800-000MedicalCareSalesBusinessReportableSegmentMember4848000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2022-05-31pass rounding
balance sheet identityconsolidated 2022-11-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-05-31pass
statement vs summary · net assetsconsolidated 2022-11-30pass
statement vs summary · net income attributable to parentconsolidated 2021-06-01/2021-11-30pass
statement vs summary · net income attributable to parentconsolidated 2022-06-01/2022-11-30pass
statement vs summary · operating cash flowconsolidated 2021-06-01/2021-11-30pass
statement vs summary · operating cash flowconsolidated 2022-06-01/2022-11-30pass
statement vs summary · revenueconsolidated 2021-06-01/2021-11-30pass
statement vs summary · revenueconsolidated 2022-06-01/2022-11-30pass
statement vs summary · total assetsconsolidated 2022-05-31pass
statement vs summary · total assetsconsolidated 2022-11-30pass